Literature DB >> 1378334

Cancer chemotherapy and quality of life.

M Byrne.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1378334      PMCID： PMC1882435          DOI： 10.1136/bmj.304.6841.1523

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  14 in total

Review 1.  Quality of life end points in cancer clinical trials: review and recommendations.

Authors:  C M Moinpour; P Feigl; B Metch; K A Hayden; F L Meyskens; J Crowley
Journal:  J Natl Cancer Inst       Date:  1989-04-05       Impact factor: 13.506

2.  Breast cancer therapy: exercising all our options.

Authors:  V T De Vita
Journal:  N Engl J Med       Date:  1989-02-23       Impact factor: 91.245

3.  Adjuvant therapy of node-negative breast cancer.

Authors:  W L McGuire
Journal:  N Engl J Med       Date:  1989-02-23       Impact factor: 91.245

4.  The effect of hypotensive drugs on the quality of life.

Authors:  S J Jachuck; H Brierley; S Jachuck; P M Willcox
Journal:  J R Coll Gen Pract       Date:  1982-02

Review 5.  Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.

Authors:  M A Poon; M J O'Connell; C G Moertel; H S Wieand; S A Cullinan; L K Everson; J E Krook; J A Mailliard; J A Laurie; L K Tschetter
Journal:  J Clin Oncol       Date:  1989-10       Impact factor: 44.544

6.  On the receiving end. IV: Validation of quality of life indicators.

Authors:  P Butow; A Coates; S Dunn; J Bernhard; C Hürny
Journal:  Ann Oncol       Date:  1991-09       Impact factor: 32.976

7.  Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.

Authors:  C G Moertel; T R Fleming; J S Macdonald; D G Haller; J A Laurie; P J Goodman; J S Ungerleider; W A Emerson; D C Tormey; J H Glick
Journal:  N Engl J Med       Date:  1990-02-08       Impact factor: 91.245

8.  Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.

Authors:  E Rapp; J L Pater; A Willan; Y Cormier; N Murray; W K Evans; D I Hodson; D A Clark; R Feld; A M Arnold
Journal:  J Clin Oncol       Date:  1988-04       Impact factor: 44.544

9.  Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis.

Authors:  A Goldhirsch; R D Gelber; R J Simes; P Glasziou; A S Coates
Journal:  J Clin Oncol       Date:  1989-01       Impact factor: 44.544

10.  Effective surgical adjuvant therapy for high-risk rectal carcinoma.

Authors:  J E Krook; C G Moertel; L L Gunderson; H S Wieand; R T Collins; R W Beart; T P Kubista; M A Poon; W C Meyers; J A Mailliard
Journal:  N Engl J Med       Date:  1991-03-14       Impact factor: 91.245
View more
  9 in total

1.  Cancer chemotherapy and fertility.

Authors:  N F Perks; A M Lower; F M Kelsey
Journal:  BMJ       Date:  1992-07-04

2.  Registration of drugs for treating cancer and HIV infection: a plea to carry out phase 3 trials before admission to the market.

Authors:  P P Koopmans
Journal:  BMJ       Date:  1995-05-20

Review 3.  Chemotherapy for solid tumours. Routine treatment not yet justified.

Authors:  G M Mead
Journal:  BMJ       Date:  1995-01-28

4.  Consumer collaboration, patient-defined outcomes and the preparation of Cochrane Reviews.

Authors:  Marcia C. Kelson
Journal:  Health Expect       Date:  1999-05       Impact factor: 3.377

5.  Discordance between physicians' estimations and breast cancer patients' self-assessment of side-effects of chemotherapy: an issue for quality of care.

Authors:  G Macquart-Moulin; P Viens; M L Bouscary; D Genre; M Resbeut; G Gravis; J Camerlo; D Maraninchi; J P Moatti
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  Quality of life assessment in clinical cancer research.

Authors:  M Olschewski; G Schulgen; M Schumacher; D G Altman
Journal:  Br J Cancer       Date:  1994-07       Impact factor: 7.640

7.  A Guide to the Language of Clinical Outcome Assessment.

Authors:  Joseph R Dettori; Daniel C Norvell; Jens R Chapman
Journal:  Global Spine J       Date:  2020-12-17

8.  Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of life.

Authors:  S C Fraser; H J Dobbs; S R Ebbs; L J Fallowfield; T Bates; M Baum
Journal:  Br J Cancer       Date:  1993-02       Impact factor: 7.640

9.  Hospice management of patients receiving cytotoxic chemotherapy: problems and opportunities.

Authors:  F Hicks; G Corcoran
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.